2025-08-25 - Analysis Report
Okay, here's an investment report based on the data you provided for Johnson & Johnson (JNJ), presented in English with a focus on key metrics and analysis.

### Investment Report: Johnson & Johnson (JNJ)

**Company Overview:** Johnson & Johnson is a global healthcare company that researches, develops, manufactures, and sells a broad range of products in the healthcare field.

**1. Performance vs. S&P 500 (VOO):**

*   **JNJ Cumulative Return:** 31.87%
*   **VOO Cumulative Return:** 38.83%
*   **Relative Divergence:** -6.95%

    *   **Range:** min: -83.0, max: 20.0
    *   **Relative Divergence (% of Range):** 14.9% (Indicates JNJ's underperformance relative to VOO is near the lower end of its historical range.)

    *Analysis:* JNJ has underperformed the S&P 500 over the analyzed period. The relative divergence suggests that this underperformance is relatively large in relation to its historical data.

*   **Alpha, Beta Analysis:**

| Year       | CAGR   | MDD   | Alpha | Beta | Cap(B) |
|------------|--------|-------|-------|------|--------|
| 2015-2017  | 28.0% | 56.1% | 28.0% | 1.0 | 336.5  |
| 2016-2018  | 8.0%  | 56.6% | 8.0%  | 1.0 | 310.8  |
| 2017-2019  | 18.0% | 56.6% | 18.0% | 1.0 | 351.3  |
| 2018-2020  | 12.0% | 59.2% | 12.0% | 1.0 | 379.0  |
| 2019-2021  | 32.0% | 59.6% | 31.0% | 0.0 | 412.0  |
| 2020-2022  | 7.0%  | 61.4% | 18.0% | -0.0 | 425.4  |
| 2021-2023  | -15.0% | 61.4% | -25.0% | -0.0 | 377.5  |
| 2022-2024  | -35.0% | 61.4% | -65.0% | -0.0 | 348.3  |
| 2023-2025  | 5.0%  | 70.1% | -40.0% | -0.0 | 431.8  |

*Analysis:* The table shows JNJ's performance metrics over different periods. It highlights CAGR (Compound Annual Growth Rate), MDD (Maximum Drawdown), Alpha (outperformance vs. benchmark), and Beta (volatility relative to the market).  Notably, Alpha has been negative in recent periods, indicating underperformance relative to the benchmark. Beta values near 0 suggest low correlation with the market. The Maximum Drawdown has increased over the most recent period, indicating higher risk.

**2. Recent Stock Price Movement:**

*   **Current Price:** 179.29
*   **Last Market Change:** +0.2
*   **5-day Moving Average:** 178.22
*   **20-day Moving Average:** 172.72
*   **60-day Moving Average:** 162.15

*Analysis:* The stock price is currently above its 5, 20, and 60-day moving averages, suggesting an upward trend in the short to medium term. The recent change of +0.2 indicates a slight positive movement in the last market session.

**3. Market Risk Indicator (MRI) and Technical Indicators:**

*   **Market Risk Indicator (MRI):** 0.3377 (Low Risk)
*   **RSI:** 84.35 (Overbought)
*   **PPO:** 0.1008
*   **Hybrid Signal:** Cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.34)
*   **20-day Relative Divergence Change:** +5.3 (Short-term increase)
*   **Expected Return (%):** -176.9%

*Analysis:* The MRI suggests a low-risk environment. However, the high RSI indicates that the stock might be overbought and could be due for a correction. The PPO(Percentage Price Oscillator)  measures the momentum of a stock. Positive values generally indicate upward momentum.  The hybrid signal suggests buying with caution. The recent increase in relative divergence suggests short-term positive momentum. The highly negative expected return indicates significant underperformance relative to the S&P 500 if held long-term (2+ years) and reinvested.

**4. Recent News & Significant Events:**

*   **2025-08-23:** Major business developments, regulatory changes, or market events.
*   **2025-08-21:** Analysts discussing performance and outlook based on industry trends and global economic factors.
*   **2025-08-22:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-08-24:** Market experts highlighting risks and opportunities, advising monitoring of news and announcements.

*Analysis:* Recent news suggests the stock is experiencing volatility and is subject to market and industry scrutiny. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis:**

| 날짜       | EPS  | 매출       |
|------------|------|------------|
| 2025-07-24 | 2.3  | 23.74 B$   |
| 2025-04-23 | 4.57 | 21.89 B$   |
| 2024-10-23 | 1.12 | 22.47 B$   |
| 2024-07-25 | 1.95 | 22.45 B$   |
| 2025-07-24 | 1.95 | 22.45 B$   |

*Analysis:* The table shows quarterly earnings per share (EPS) and revenue. EPS has fluctuated. Revenue shows variability over the quarters analyzed.

**6. Financial Information:**

Revenue and Profitability:

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-06-30 | $23.74B   | 67.87%        |
| 2025-03-31 | $21.89B   | 66.40%        |
| 2024-12-31 | $22.52B   | 68.35%        |
| 2024-09-30 | $22.47B   | 69.01%        |
| 2024-06-30 | $22.45B   | 69.40%        |

Capital and Profitability:

| Quarter    | Equity     | ROE     |
|------------|------------|---------|
| 2025-06-30 | $78.47B   | 7.06%   |
| 2025-03-31 | $78.11B   | 14.08%  |
| 2024-12-31 | $71.49B   | 4.80%   |
| 2024-09-30 | $70.16B   | 3.84%   |
| 2024-06-30 | $71.54B   | 6.55%   |

*Analysis:* Revenue has shown some increase in the most recent quarter, while profit margins remain consistently high. Equity has increased over the period, and ROE (Return on Equity) has fluctuated significantly, indicating variability in how effectively the company is using equity to generate profits.

**7. Overall Analysis & Conclusion:**

Johnson & Johnson (JNJ) exhibits a mixed investment profile. While recent price movement suggests a short-term upward trend and the company maintains strong profitability, it has underperformed the S&P 500. The high RSI indicates that the stock may be overbought in the short term.  The recent news indicates some volatility and market scrutiny.

*   **Strengths:** Low Market Risk Indicator, high profit margins, relatively stable revenue, recent upward price movement.
*   **Weaknesses:** Underperformance relative to the S&P 500, high RSI (potentially overbought), negative long-term expected return relative to the S&P 500, recent period of negative Alpha.

*   **Recommendation:** Given the mixed signals, a cautious approach is warranted. Investors should monitor JNJ's performance and news closely, especially in light of the recent volatility. The current hybrid signal of "Cash_0%_Buy 80% of cash" suggests a cautious buying strategy.

